Free Trial

Viracta Therapeutics (VIRX) Short Interest Ratio & Short Volume

Viracta Therapeutics logo
$0.15 0.00 (-1.84%)
(As of 12:20 PM ET)

Viracta Therapeutics Short Interest Data

Viracta Therapeutics (VIRX) has a short interest of 2.69 million shares, representing 9.71% of the float (the number of shares available for trading by the public). This marks a 144.55% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 492,406 shares to cover all short positions.

Current Short Interest
2,690,000 shares
Previous Short Interest
1,100,000 shares
Change Vs. Previous Month
+144.55%
Dollar Volume Sold Short
$542,842.00
Short Interest Ratio
1.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
39,740,000 shares
Float Size
27,710,000 shares
Short Percent of Float
9.71%
Today's Trading Volume
109,568 shares
Average Trading Volume
492,406 shares
Today's Volume Vs. Average
22%
Short Selling Viracta Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Viracta Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VIRX Short Interest Over Time

VIRX Days to Cover Over Time

VIRX Percentage of Float Shorted Over Time

Viracta Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20242,690,000 shares $542,842.00 +144.6%9.7%1.9 $0.20
10/15/20241,100,000 shares $241,560.00 -17.3%4.0%1.7 $0.22
9/30/20241,330,000 shares $307,762.00 +1.5%4.8%2.1 $0.23
9/15/20241,310,000 shares $328,810.00 +4.0%4.7%2.1 $0.25
8/31/20241,260,000 shares $269,136.00 -50.4%4.6%2.1 $0.21
8/15/20242,540,000 shares $885,190.00 +178.5%9.2%4.8 $0.35
7/31/2024912,000 shares $436,848.00 -6.4%3.3%8.5 $0.48
7/15/2024974,800 shares $517,618.80 +35.2%3.5%10.7 $0.53
6/30/2024721,000 shares $392,007.70 +1.7%2.6%7 $0.54
6/15/2024708,900 shares $477,656.82 +3.8%2.6%6.7 $0.67
5/31/2024682,700 shares $477,890.00 +2.1%2.5%6.3 $0.70
5/15/2024668,400 shares $561,456.00 -4.4%2.4%6.5 $0.84
4/30/2024699,400 shares $573,228.24 +1.9%2.5%6.3 $0.82
4/15/2024686,700 shares $535,626.00 +6.0%2.5%6.2 $0.78
3/31/2024648,000 shares $660,960.00 +2.2%2.4%6.8 $1.02
3/15/2024634,300 shares $631,762.80 -7.1%2.3%5.7 $1.00
2/29/2024683,000 shares $556,645.00 +0.6%2.5%5 $0.82
2/15/2024678,800 shares $433,753.20 +4.5%2.5%4.5 $0.64
1/31/2024649,900 shares $370,443.00 +0.4%2.4%4 $0.57
1/15/2024647,500 shares $384,226.50 -1.9%2.4%3.8 $0.59
12/31/2023660,300 shares $376,371.00 -14.9%2.5%3.8 $0.57
12/15/2023776,100 shares $361,973.04 +19.3%2.9%4.6 $0.47
11/30/2023650,700 shares $316,890.90 -8.2%2.4%4.9 $0.49
11/15/2023708,700 shares $425,503.48 +3.0%2.6%7.3 $0.60
10/31/2023688,200 shares $424,275.30 +12.0%2.6%7.5 $0.62
10/15/2023614,700 shares $436,437.00 -2.7%2.3%7.6 $0.71
9/30/2023632,000 shares $657,280.00 -4.3%2.4%7 $1.04
9/15/2023660,200 shares $838,454.00 -5.3%2.5%7.8 $1.27
8/31/2023697,200 shares $1.00 million -4.4%2.6%6.8 $1.44
8/15/2023729,100 shares $947,830.00 +5.2%2.7%4.5 $1.30
7/31/2023692,900 shares $1.07 million -3.9%2.6%2.8 $1.55
7/15/2023721,000 shares $1.05 million -1.0%2.7%2.9 $1.45
6/30/2023728,500 shares $1.03 million -7.8%2.8%3 $1.41
6/15/2023789,900 shares $1.26 million +14.0%3.0%3.3 $1.59
5/31/2023693,200 shares $921,956.00 +12.4%2.6%3.2 $1.33
5/15/2023616,700 shares $807,877.00 -2.2%2.3%3.4 $1.31
4/30/2023630,800 shares $813,732.00 +2.0%2.4%8.4 $1.29
4/15/2023618,300 shares $902,718.00 -2.5%2.3%9.6 $1.46
3/31/2023634,000 shares $1.01 million -19.5%2.4%8.4 $1.59
3/15/2023787,800 shares $1.33 million +51.7%3.0%8.7 $1.69
Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

2/28/2023519,200 shares $882,640.00 +3.9%2.0%4.9 $1.70
2/15/2023499,500 shares $994,005.00 +5.6%1.9%4.5 $1.99
1/31/2023473,000 shares $983,840.00 -2.5%1.8%3.8 $2.08
1/15/2023485,300 shares $1.10 million +3.2%1.8%3.9 $2.26
12/30/2022470,300 shares $686,638.00 -15.1%1.8%3.8 $1.46
12/15/2022553,600 shares $1.06 million -0.1%2.1%5.2 $1.92
11/30/2022553,900 shares $1.29 million +7.3%2.1%5.1 $2.32
11/15/2022516,200 shares $1.50 million +8.8%2.0%4.8 $2.90
10/31/2022474,600 shares $1.87 million -9.6%1.9%4.7 $3.93
10/15/2022525,100 shares $1.97 million -4.4%2.0%5.1 $3.75
9/30/2022549,000 shares $2.34 million +9.3%2.1%5 $4.27
9/15/2022502,100 shares $2.81 million -3.9%2.0%2.6 $5.59
8/31/2022522,300 shares $2.12 million +0.6%2.0%2.3 $4.05
8/15/2022519,100 shares $2.29 million -8.2%2.0%2.2 $4.42
7/31/2022565,400 shares $1.88 million -16.1%1.9%2.2 $3.32
7/15/2022673,800 shares $2.99 million -32.5%2.3%2.5 $4.44
6/30/2022998,500 shares $3.87 million -48.5%3.4%3.2 $3.88
6/15/20221,940,000 shares $4.85 million -3.0%6.5%6.1 $2.50
5/31/20222,000,000 shares $4.24 million +8.7%6.7%8.1 $2.12
5/15/20221,840,000 shares $3.44 million -7.1%6.2%7.3 $1.87
4/30/20221,980,000 shares $5.05 million +16.5%6.7%6.2 $2.55
4/15/20221,700,000 shares $6.90 million +20.6%5.7%5.2 $4.06
3/31/20221,410,000 shares $6.71 million +20.5%4.8%4.7 $4.76
3/15/20221,170,000 shares $2.61 million +13.6%3.9%4.2 $2.23
2/28/20221,030,000 shares $2.81 million +7.8%3.5%3.5 $2.73
2/15/2022955,900 shares $2.98 million +26.0%3.2%3 $3.12
1/31/2022758,800 shares $2.03 million +5.5%2.7%2.9 $2.68
1/15/2022719,100 shares $2.28 million -15.4%2.5%3.3 $3.17
12/31/2021849,800 shares $3.10 million -2.7%3.0%3.7 $3.65
12/15/2021873,100 shares $3.12 million +30.4%3.1%4 $3.57
11/30/2021669,400 shares $3.09 million -24.3%2.4%3.8 $4.61
11/15/2021884,500 shares $4.93 million -15.0%3.1%5.5 $5.57
10/29/20211,040,000 shares $6.12 million -7.1%3.5%6.6 $5.88
10/15/20211,120,000 shares $7.25 million -1.8%3.8%7.5 $6.47
9/30/20211,140,000 shares $9.14 million -5.0%3.8%8.5 $8.02
9/15/20211,200,000 shares $10.08 million -9.1%4.0%5.5 $8.40
8/31/20211,320,000 shares $12.17 million -15.9%4.4%4.9 $9.22
8/13/20211,570,000 shares $16.11 million No Change5.3%5.7 $10.26

VIRX Short Interest - Frequently Asked Questions

What is Viracta Therapeutics' current short interest?

Short interest is the volume of Viracta Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 2,690,000 shares of VIRX short. 9.71% of Viracta Therapeutics' shares are currently sold short. Learn More on Viracta Therapeutics' current short interest.

What is a good short interest ratio for Viracta Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIRX shares currently have a short interest ratio of 2.0. Learn More on Viracta Therapeutics's short interest ratio.

What is a good short interest percentage for Viracta Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.71% of Viracta Therapeutics' floating shares are currently sold short.

Is Viracta Therapeutics' short interest increasing or decreasing?

Viracta Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 2,690,000 shares, an increase of 144.5% from the previous total of 1,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Viracta Therapeutics' float size?

Viracta Therapeutics currently has issued a total of 39,740,000 shares. Some of Viracta Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Viracta Therapeutics currently has a public float of 27,710,000 shares.

How does Viracta Therapeutics' short interest compare to its competitors?

9.71% of Viracta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Viracta Therapeutics: Calidi Biotherapeutics, Inc. (7.72%), Tempest Therapeutics, Inc. (11.82%), Chemomab Therapeutics Ltd. (1.29%), Cocrystal Pharma, Inc. (0.03%), Acurx Pharmaceuticals, Inc. (3.43%), Pulmatrix, Inc. (0.19%), Exicure, Inc. (4.71%), MIRA Pharmaceuticals, Inc. (12.65%), Pieris Pharmaceuticals, Inc. (1.70%), Cyclo Therapeutics, Inc. (0.69%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Viracta Therapeutics stock?

Short selling VIRX is an investing strategy that aims to generate trading profit from Viracta Therapeutics as its price is falling. VIRX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Viracta Therapeutics?

A short squeeze for Viracta Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VIRX, which in turn drives the price of the stock up even further.

How often is Viracta Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIRX, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:VIRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners